Why Supplement NDA and Intellectual Property Protection Matters for Brand Owners

At SREKE, we understand that your proprietary formulations, trade secrets, and brand identity are among your most valuable assets. When you partner with a contract manufacturer for OEM or ODM production, the risk of intellectual property exposure increases significantly. A well-structured Non-Disclosure Agreement (NDA) and a clear IP protection framework are not optional — they are essential safeguards for any supplement brand owner operating in a competitive global market.

According to the International Trade Administration, the dietary supplement industry in the United States alone exceeded $18 billion in annual retail sales as of recent FDA and IBISWorld market analyses. With this growth comes heightened competition and a corresponding rise in formulation theft and IP disputes. Brand owners who fail to protect their proprietary blends, unique delivery systems, or novel ingredient combinations risk losing their market advantage to competitors who may reverse-engineer or replicate their products.

Under U.S. FDA regulations, supplement manufacturers must comply with 21 CFR Part 111 (Current Good Manufacturing Practice for Dietary Supplements), which requires documented procedures for maintaining the confidentiality of proprietary formulas. Similarly, the European Food Safety Authority (EFSA) and EU regulation (EC) No 178/2002 establish traceability and food safety documentation standards that indirectly reinforce the need for robust IP controls throughout the supply chain. At SREKE, our Guangzhou manufacturing facility operates under GMP certification and maintains strict confidentiality protocols aligned with both FDA and international compliance requirements.

Key Manufacturing Considerations at SREKE

Non-Disclosure Agreements (NDAs)

At SREKE, we require every client to sign a mutual Non-Disclosure Agreement before any formulation discussion, sample development, or pricing quotation begins. Our standard NDA covers the following protections:

• Proprietary formulas, ingredient ratios, and dosage specifications shared during the development process
• Technical specifications, packaging designs, and label artwork
• Business terms, pricing structures, and order volumes
• Any trade secrets or unique manufacturing processes discussed

Our NDAs are governed by applicable contract law and typically include a confidentiality period of three to five years, extendable by mutual agreement. We recommend that brand owners also engage legal counsel to review any NDA before signing, ensuring it aligns with their specific jurisdiction and business needs.

Intellectual Property Protection Framework

Beyond NDAs, SREKE implements several structural safeguards to protect your intellectual property throughout the manufacturing lifecycle:

• Segregated production lines: Proprietary formulations are manufactured on dedicated or scheduled production runs to prevent cross-contamination of intellectual property between clients.
• Restricted access protocols: Only authorized personnel with a documented need-to-know are granted access to your formulation details, batch records, and packaging specifications.
• Confidential batch coding: We assign internal batch identifiers that do not reveal your brand name or proprietary ingredient information on production documentation.
• Secure data storage: All formulation files, test reports, and client communications are stored on encrypted servers with restricted access logs, consistent with FDA 21 CFR Part 11 requirements for electronic records.
• Ingredient supplier confidentiality: When we source specialty ingredients on your behalf, we require our suppliers to sign confidentiality agreements, creating a chain of protection from raw material to finished product.

Formulation Development and IP Ownership

A critical distinction in any OEM/ODM partnership is who owns the intellectual property in the final formulation. At SREKE, we operate under a clear principle: formulations developed exclusively for a client using that client's proprietary ingredients, specifications, or concepts are the intellectual property of the client. Our standard ODM framework includes written confirmation of IP ownership transferred to the brand owner upon finalization of the formulation.

For ODM programs where SREKE contributes existing proprietary technology or base formulations, we clearly disclose the scope of IP rights during the initial consultation. This transparency ensures there are no ambiguities regarding ownership, licensing, or exclusivity — a practice that aligns with FDA guidance on maintaining accurate and complete records of dietary supplement production and quality control.

Compliance with GMP, ISO, and HACCP Standards

Our manufacturing facility in Guangzhou holds GMP certification and adheres to ISO 22000 and HACCP principles for food safety management. These standards require documented procedures for controlling confidential information and preventing unauthorized disclosure — reinforcing the IP protection framework we provide to every client. Compliance with these internationally recognized standards also ensures that your product meets the regulatory requirements for export to the United States, the European Union, Southeast Asia, and other key markets.

How SREKE Helps You Get to Market Faster

At SREKE, we recognize that speed to market is a competitive advantage in the supplement industry. Our streamlined OEM and ODM processes are designed to reduce development time without compromising on quality, compliance, or intellectual property protection.

Development and Prototyping

• MOQ flexibility: We offer competitive minimum order quantities tailored to your stage of growth, whether you are launching a new brand or scaling an existing product line.
• Formulation development: Our in-house R&D team can develop custom formulations or adapt existing ODM formulas to meet your specifications, typically completing prototype samples within 7 to 14 business days.
• Regulatory compliance review: We assist with FDA dietary supplement labeling compliance (21 CFR Part 101.36), including proper Supplement Facts panel formatting, structure/function claim language, and ingredient disclosure requirements. For EU market access, we support compliance with EFSA health claim regulations and novel food requirements.

Manufacturing and Lead Times

Our standard production lead time ranges from 25 to 45 days depending on product type, order volume, and packaging complexity. Softgels, capsules, and tablets typically require the shortest turnaround, while gummies and liquid formulations may involve additional processing steps. We provide real-time production tracking so you can plan your launch timeline with confidence.

Packaging and Private Label Solutions

SREKE offers comprehensive packaging support, including:

• Custom bottle, blister pack, and sachet design
• Private label printing with your brand artwork
• Compliance-ready label review for FDA and destination-market regulations
• Child-resistant and tamper-evident closure options
• Sustainable and eco-friendly packaging alternatives

Quality Assurance and Testing

Every batch produced at SREKE undergoes rigorous quality testing, including identity testing of raw ingredients, potency verification, heavy metal screening, microbial analysis, and stability testing where required. Our quality management system is designed to produce products that meet or exceed FDA cGMP standards and EFSA requirements for dietary supplements marketed in the European Union.

Industry Trends and Market Opportunities

The global dietary supplement market is projected to continue its expansion, with Grand View Research estimating the market size to reach approximately $720 billion by 2030. Several trends are shaping how brand owners approach formulation, manufacturing partnerships, and intellectual property strategy:

• Proprietary ingredient blends: Consumers and brands alike are gravitating toward unique, patent-pending ingredient combinations. Protecting these formulations through NDAs and IP agreements is more important than ever.
• Clean-label and transparency demands: Regulatory bodies including the FDA and EFSA are increasing scrutiny on supplement labeling accuracy. Partnering with a GMP-certified manufacturer like SREKE ensures your claims are substantiated and your labels are compliant.
• Emerging market access: Brand owners expanding into Asia-Pacific, Middle Eastern, and European markets must navigate diverse regulatory landscapes. SREKE's experience with international compliance helps you enter new markets efficiently.
• Contract manufacturing consolidation: As the industry matures, brand owners are seeking long-term OEM/ODM partners who can provide end-to-end solutions — from formulation development and IP protection to manufacturing, quality assurance, and logistics.

At SREKE, we stay ahead of these trends by investing in R&D, maintaining current certifications, and continuously refining our confidentiality and IP protection protocols. Our goal is to be the manufacturing partner you can trust with your most valuable assets — your formulations and your brand.

Frequently Asked Questions

What is an NDA in supplement manufacturing?

An NDA (Non-Disclosure Agreement) is a legally binding contract between a supplement brand owner and a contract manufacturer that prohibits the manufacturer from disclosing or using the brand owner's proprietary information — including formulations, ingredient sourcing, packaging designs, and business terms — without authorization. At SREKE, we require an NDA before any confidential discussions begin.

Who owns the intellectual property in a custom formulation?

In a standard OEM arrangement, the brand owner retains full ownership of any formulation developed exclusively to their specifications. At SREKE, we document IP ownership in writing before production begins. For ODM formulations that incorporate our existing base technology, we clearly define the scope of rights and licensing during the initial consultation.

Does SREKE hold my formulation data after the contract ends?

Yes, we retain formulation and production records as required by FDA 21 CFR Part 111, which mandates that dietary supplement records be kept for at least one year past the shelf life of the product. However, these records remain confidential and are not accessible to third parties without your written authorization.

Can SREKE manufacture for multiple clients with similar product categories?

Yes. We work with multiple brand owners in various supplement categories. However, we maintain strict separation of proprietary formulations and implement production scheduling that prevents any sharing of confidential information between clients. Each formulation is treated as unique intellectual property.

What certifications does SREKE hold?

SREKE's manufacturing facility in Guangzhou is GMP-certified and operates under ISO 22000 and HACCP food safety management systems. These certifications demonstrate our commitment to quality, traceability, and the protection of client intellectual property throughout the manufacturing process.

What are the typical MOQ and lead times at SREKE?

Our MOQ varies by product type and packaging, and we work with brands at every stage of growth. Standard production lead times range from 25 to 45 days. We provide detailed timelines during the quoting process so you can plan your launch with confidence.

How does SREKE ensure compliance with FDA and EFSA regulations?

Our quality assurance team maintains documentation and production procedures that comply with FDA 21 CFR Part 111 (cGMP for dietary supplements) and relevant EFSA requirements for products destined for the European market. We conduct incoming ingredient testing, in-process quality checks, and finished product testing to verify compliance.